


The widespread use of antiresorptive therapy is unlikely to reduce this fracture burden because of a paucity of evidence of antifracture efficacy in people over 80 years of age, the common occurrence of adverse events, and high cost given the large numbers of people that must be treated. 2 Thus, targeting an intervention to all aged care residents is a rational approach to reducing the fracture burden in the whole community. 1 Loss of independence increases the number of people needing full time institutionalised care, the source of around 30% of all hip fractures in the community.

The accompanying increased prevalences of chronic illnesses, loss of musculoskeletal mass, frailty, and bone fragility increase the risk of falls and fractures. Longevity increases the proportion of older adults in the population.
